![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Found 82 studies with search of: | Open Studies | "Antiretroviral Therapy, Highly Active" OR HAART |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)
|
||||
2 | Recruiting |
Early Initiation of HAART
|
||||
3 | Recruiting |
Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients
|
||||
4 | Recruiting |
Neurocognitive Assessment and HAART
|
||||
5 | Not yet recruiting |
Effectiveness of Antiretroviral Therapy During Acute HIV Infection
|
||||
6 | Recruiting |
Anti-HIV Medications for People Recently Infected With HIV
|
||||
7 | Recruiting |
Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)
|
||||
8 | Recruiting |
Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
|
||||
9 | Recruiting |
Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-Infected Adults (ANRS 12136 TEMPRANO)
|
||||
10 | Recruiting |
Longitudinal Study of Ocular Complications of AIDS (LSOCA)
|
||||
11 | Recruiting |
HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT
|
||||
12 | Not yet recruiting |
Routine Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission in the Kafue District of Zambia
|
||||
13 | Recruiting |
Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients
|
||||
14 | Recruiting |
An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)
|
||||
15 | Recruiting |
RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)
|
||||
16 | Recruiting |
Raltegravir Added to Stable Highly Active Antiretroviral Therapy (HAART) in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery
|
||||
17 | Recruiting |
Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy
|
||||
18 | Recruiting |
Isoniazid Plus HAART to Prevent TB in HIV-Infected Persons
|
||||
19 | Recruiting |
Kaletra-Isentress Treatment Evaluation
|
||||
20 | Recruiting |
The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART
|
![]() |
Previous Page | Studies Shown (1-20) | Next (21-40) |
![]() |